Canine CA50 antibody and antigen (recombinant protein)

Diagnostic anti-Canine CA50 antibodies pairs and antigen for animal health (animal Dog/Canine pancreatic and colorectal cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Companion Animal disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-CAN-CA50-Ag01Canine CA50$3090.00
GMP-CAN-CA50-Ab01Anti-Canine CA50 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-CA50-Ab02Anti-Canine CA50 mouse monoclonal antibody (mAb)$3090.00
GMP-CAN-CA50-Ab03Anti-Canine CA50 human monoclonal antibody (mAb)$3090.00
GMP-CAN-CA50-Ab04Anti-Canine CA50 human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-CAN-CA50-Ag01
Product NameCanine CA50
Target/BiomarkerCanine CA50
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Canine CA50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer.
TagHis
Reconized/Reactive SpecicsCanine CA50
Product descriptionRecombinant Canine CA50 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-CA50-Ab01,GMP-CAN-CA50-Ab02
Target/BiomarkerCanine CA50
Product NameAnti-Canine CA50 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Canine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies in Canine CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer.
Product descriptionAnti-Canine CA50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-CAN-CA50-Ab03,GMP-CAN-CA50-Ab04
Target/BiomarkerCanine CA50
Product NameAnti-Canine CA50 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Canine CA50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine CA50 antibodies in Canine CA50 level test of animal Dog/Canine with pancreatic and colorectal cancer.
Product descriptionAnti-Canine CA50 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Carbohydrate Antigen 50 (CA50) is a glycoprotein biomarker with vital implications in canine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in dogs, with a significant focus on those affecting the gastrointestinal and pancreatic regions. Structurally, CA50 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules.

    In the context of canine health, CA50 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA50 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes.

    CA50 levels in a dog's bloodstream become elevated when cancer cells, particularly those found in gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA50 serves as a biomarker that can be readily detected and quantified through blood tests.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.